Abstract
Large and giant aneurysms account for up to 5% of all intracranial aneurysms approximately. They often present during the fifth to seventh decades and have a female predominance. Unlike small aneurysms which often present with subarachnoid hemorrhage (SAH), giant aneurysms often present with symptoms of mass effect, ischemia [1]. Ischemia is mostly due to the development of thromboembolism. Approximately 17–33% of giant aneurysms were thrombotic. Though many cases follow mild and calm progression for long periods, some have rapid progression to large sizes [1, 2]. The risk of rupture of these giant aneurysms is approximately 50% in 5 years according to the International Study of Unruptured Intracranial Aneurysms (ISUIA) trial.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Malaspinas O, Turjman A. Ribeiro de Sousa D, et al. a spatio-temporal model for spontaneous thrombus formation in cerebral aneurysms. J Theor Biol. 2016;394:68–76. https://doi.org/10.1016/j.jtbi.2015.12.022.
Cohen JE, Yitshayek E, Gomori JM, et al. Spontaneous thrombosis of cerebral aneurysms presenting with ischemic stroke. J Neurol Sci. 2007;254(1–2):95–8. https://doi.org/10.1016/j.jns.2006.12.008.
Whittle IR, Dorsch NW, Besser M. Spontaneous thrombosis in giant intracranial aneurysms. J Neurol Neurosurg Psychiatry. 1982;45(11):1040–7. https://doi.org/10.1136/jnnp.45.11.1040.
Chung I, Lip GYH. Virchow’ s triad revisited: blood constituents; 2004, pp. 449–454.
Suzuki H, Mikami T, Tamada T, et al. Inflammation promotes progression of thrombi in intracranial thrombotic aneurysms. Neurosurg Rev. 2019; https://doi.org/10.1007/s10143-019-01184-3.
Fogelson AL, Neeves KB. Fluid mechanics of blood clot formation. Annu Rev Fluid Mech. 2015;47(1):377–403. https://doi.org/10.1146/annurev-fluid-010814-014513.
Hashimoto T, Meng H, Young WL. Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res. 2006;28(4):372–80. https://doi.org/10.1179/016164106X14973.
Mizutani T, Goldberg HI, Parr J, Harper C, Thompson CJ. Cerebral dissecting aneurysm and intimal fibroelastic thickening of cerebral arteries. Case report. J Neurosurg. 1982;56(4):571–6. https://doi.org/10.3171/jns.1982.56.4.0571.
Kataoka K, Taneda M, Asai T, Kinoshita A, Ito M, Kuroda R. Structural fragility and inflammatory response of ruptured cerebral aneurysms: a comparative study between ruptured and unruptured cerebral aneurysms. Stroke. 1999; https://doi.org/10.1161/01.STR.30.7.1396.
Tulamo R, Frösen J, Hernesniemi J, Niemelä M. Inflammatory changes in the aneurysm wall: a review. J Neurointerv Surg. 2010;2(2):120–30. https://doi.org/10.1136/jnis.2009.002055.
Signorelli F, Sela S, Gesualdo L, et al. Hemodynamic stress, inflammation, and intracranial aneurysm development and rupture: a systematic review. World Neurosurg. 2018;115 https://doi.org/10.1016/j.wneu.2018.04.143.
Krings T, Piske RL, Lasjaunias PL. Intracranial arterial aneurysm vasculopathies: targeting the outer vessel wall. Neuroradiology. 2005;47(12):931–7. https://doi.org/10.1007/s00234-005-1438-9.
Krings T, Lasjaunias PL, Geibprasert S, Pereira V, Hans FJ. The aneurysmal wall. The key to a subclassification of intracranial arterial aneurysm vasculopathies? Interv Neuroradiol. 2008;14(SUPPL. 1):39–47. https://doi.org/10.1177/15910199080140S107.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Devareddy, G. (2021). Pathogenesis of Thrombosed Giant Aneurysm. In: Kato, Y., Zhang, X., Dai, J., Ansari, A. (eds) Recent Progress in the Management of Cerebrovascular Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-16-3387-4_2
Download citation
DOI: https://doi.org/10.1007/978-981-16-3387-4_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-3386-7
Online ISBN: 978-981-16-3387-4
eBook Packages: MedicineMedicine (R0)